Role of Human Leucocyte Antigen (HLA) Class II Gene Polymorphism in Type 1 Diabetes Mellitus

2016 ◽  
Vol 25 (2) ◽  
pp. 109-115
Author(s):  
Basma Abd Elmoez Ali ◽  
Wafaa K. M. Mahdi ◽  
Doaa Mohammed Mahrous
Medicina ◽  
2010 ◽  
Vol 46 (8) ◽  
pp. 505 ◽  
Author(s):  
Erika Skrodenienė ◽  
Dalia Marčiulionytė ◽  
Žilvinas Padaiga ◽  
Edita Jašinskienė ◽  
Vaiva Sadauskaitė-Kuehne ◽  
...  

Objective. Type 1 diabetes mellitus is a slowly progressive autoimmune disease. The genetic background of type 1 diabetes mellitus is polygenic with the major disease locus located in the human leukocytes antigen (HLA) region. High risk and protective alleles, haplotypes, and genotypes have been determined in Lithuanian children with type 1 diabetes mellitus and healthy children. Material and methods. In this case-control study, 124 children with diabetes (55 males and 69 females; mean age, 9.2±3.9 years) were tested for HLA class II and compared with 78 healthy controls (43 males and 35 females; mean age, 10.8±3.4 years; range, 0–15 years). HLA DRB1, DQA1, and DQB1 alleles were genotyped using a polymerase chain reaction. Results. T1D risk-associated haplotypes (DR4)-DQA1*0301-DQB1*0302, (DR3)- DQA1*0501-DQB1*0201, and (DR1)-DQA1*0101-04-DQB1*0501 were more prevalent among children with diabetes than controls (50.0%, 41.1%, and 37.9% vs. 10.3%, 5.1%, and 24.4%, P<0.001). The haplotypes (DR4)-DQA1*0301-DQB1*0302 and (DR3)-DQA1*0501-DQB1*0201 increased T1D risk by 8.75 and 12.93 times, respectively (P<0.001). Protective haplotypes (DR2)- DQA1*0102-B1*0602, (DR11/12/13)-DQA1*05-DQB1*0301, and (DR13)-DQA1*0103- DQB1*0603 were significantly more prevalent among controls than children with diabetes (25.6%, 33.3%, 19.2% vs. 0%, 3.2%, 0%; P<0.001). These frequencies are quite similar to those from neighbor countries with varying incidence of type 1 diabetes mellitus. Conclusions. HLA class II haplotypes associated with type 1 diabetes mellitus positively or negatively were the same in Lithuanian children as in other European Caucasian populations. Differences in incidence and clinical manifestations of type 1 diabetes might be due to different environmental factors and/or lifestyle.


2013 ◽  
Vol 20 (1) ◽  
pp. 12 ◽  
Author(s):  
Oindrila Raha ◽  
Biswanath Sarkar ◽  
Bhaskar VKS Lakkakula ◽  
Veerraju Pasumarthy ◽  
Sudhakar Godi ◽  
...  

2007 ◽  
Vol 68 (7) ◽  
pp. 616-622 ◽  
Author(s):  
Dania Hirsch ◽  
Ronit Narinski ◽  
Tirza Klein ◽  
Shoshana Israel ◽  
Joelle Singer

2001 ◽  
Vol 2 (3) ◽  
pp. 98-102 ◽  
Author(s):  
Ondrej Cinek ◽  
Stanislava Koloušková ◽  
Marta Šnajderová ◽  
Zdeněk Šumník ◽  
P Sedláková ◽  
...  

2021 ◽  
Vol 23 (4) ◽  
pp. 895-902
Author(s):  
A. A. Voropai ◽  
M. A. Levkovich ◽  
G. A. Galkina ◽  
M. V. Komkova ◽  
M. V. Morozova

Long-term complications of type 1 diabetes mellitus (T1DM) in children and adolescents are an important problem in modern medicine. Recently, the role of immune mechanisms, in particular, chronic inflammation, in the development of both T1DM and its microvascular complications has been actively discussed. Activation of Toll-like receptor 2 (TLR2) and Toll-like receptor 4 (TLR4) leads to hyperproduction of proinflammatory cytokines, chemokines, adhesion molecules involved in the formation of diabetic microvascular complications. At the same time, TLR2 and TLR4 gene polymorphism alters the immune susceptibility to the endogenous ligands, which may increase the risk of diabetic microangiopathies. The aim of this study is to evaluate the frequency of genotypes and alleles of TLR2 and TLR4 genes distribution and to determine the content of TNFα, IL-1, VCAM-1, fractalkine, endothelin-1 in adolescents with T1DM with microvascular complications. We examined 139 adolescents with T1DM from 14 to 18 years old and 56 healthy teenagers. Patients with T1DM were divided into two groups: Group I – patients with poor glycemic control (HbA1C > 9.0%), (n = 64); Group II – patients with satisfactory glycemic control of T1DM (HbA1C ≤ 9.0%), (n = 75), including adolescents with optimal (HbA1C < 7.5%) and suboptimal glycemic control (7.5% ≤ HbA1C ≤ 9.0%) (ISPAD clinical practice consensus guidelines 2014). According to the presence of microvascular complications, the groups were subdivided into subgroups: Iа (n = 49), IIа (n = 38) – adolescents with verified microvascular disorders: diabetic retinopathy, nephropathy and neuropathy; Ib (n = 15), IIb (n = 37) – without microvascular complications. Allelic variants of TLR genes were determined using test systems GosNII genetics (Moscow). The content of cytokines in blood serum was carried out by the method of enzyme-linked immunosorbent assay “BIOSCIENCE”. Data were analyzed using software packages Statistica version 6.0. The assessment of TLR2 (Arg753Gln) and TLR4 (Thr399Ile) polymorphism distribution did not reveal significant differences between the observed subgroups and the control. In Ia and IIa subgroups (with complications) Asp299Gly variant was noted to be significantly less common when compared to subgroups Ib, IIb and controls. The presence of Gly allele in TLR4 gene was found to disrupt the expression of TNFα and VCAM-1 and can be considered protective for the development of microvascular complications. 


2001 ◽  
Vol 57 (2) ◽  
pp. 144-150 ◽  
Author(s):  
R.F. Schipper ◽  
B.P.C. Koeleman ◽  
G.J. Bruining ◽  
G.M.tH. Schreuder ◽  
W. Verduijn ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document